Julio Rosenstock

Julio Rosen stock, MD, is director of the Dallas Diabetes Research Centre at Medical City and clinical professor of medicine at the University of Texas South-western Medical Centre in Dallas. He received his MD from the University Of Costa Rica School Of Medicine and completed fellowships in endocrinology and diabetes at the Royal Postgraduate Medical School, Hammersmith Hospital, in London, UK, and at the University of Texas South-Western Medical Centre. He is board-certified in internal medicine, endocrinology, and metabolism. His clinical and research activities have focused on exploring novel agents and therapeutic strategies to improve glycemic control, particularly early insulin intervention with combination strategies in type 2 diabetes. He has contributed to the development of the concept of fixed-ratio combinations of basal insulin with a GLP-1 receptor agonist (GLP-1 RA). Over the past 30 years, he has participated in hundreds of clinical trials and played an active role in the development of new oral agents and insulin preparations, often serving as a lead clinical investigator and scientific advisor. He has authored or co-authored more than 470 publications, including peer-reviewed papers and numerous abstracts. He has also contributed to several clinical publications and book chapters on various topics in diabetes. He currently serves as an associate editor of Diabetes Care, a member of the editorial boards of Practical Diabetology and Cardiovascular Diabetology, and an active reviewer for several journals. He has chaired or served as a featured speaker at numerous lectures and presentations nationally and internationally.